Key facts
- Active Substance
- Pollen from Dactylis glomerata, Festuca pratensis, Lolium perenne, Phleum pratense, Poa pratensis, Secale cereale and Artemisia vulgaris
- Therapeutic area
- Pneumology-allergology
- Decision number
- P/298/2010
- PIP number
- EMEA-000851-PIP01-10
- Pharmaceutical form(s)
- Suspension for injection
- Condition(s) / indication(s)
- Treatment of rhino-conjuctivitis
- Treatment of allergic rhinitis
- Route(s) of administration
- Subcutaneous use
- Contact for public enquiries
ALK-Abelló A/S
lcndk@alk-abello.com
ALKMRPdk@alk-abello.com
Denmark
Phone: +45 45748037
Fax: +45 45748600- Decision type
- P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
- Decision date